BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND PIK3R1, P27986, 5295, ENSG00000145675, p85-ALPHA, GRB1 AND Diagnosis
5 results:

  • 1. Bioinformatics and In silico approaches to identify novel biomarkers and key pathways for cancers that are linked to the progression of female infertility: A comprehensive approach for drug discovery.
    Hossain MA; Sohel M; Rahman MH; Hasan MI; Khan MS; Amin MA; Islam MZ; Peng S
    PLoS One; 2023; 18(1):e0265746. PubMed ID: 36608061
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Melanotic medullary thyroid carcinoma: A case report with review of the literature.
    Brzezinska KA; Bhardwaj S; Teng MS; Si Q; Sun J; Westra WH; Zakowski MF; Szporn AH
    Diagn Cytopathol; 2023 Jan; 51(1):E14-E20. PubMed ID: 36056712
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Accumulated promoter methylation as a potential biomarker for esophageal cancer.
    Peng X; Xue H; Lü L; Shi P; Wang J; Wang J
    Oncotarget; 2017 Jan; 8(1):679-691. PubMed ID: 27893424
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway.
    Chen CH; Lai JM; Chou TY; Chen CY; Su LJ; Lee YC; Cheng TS; Hong YR; Chou CK; Whang-Peng J; Wu YC; Huang CY
    PLoS One; 2009; 4(4):e5052. PubMed ID: 19337377
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
    Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
    Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.